Abacus Wealth Partners’s Dr. Reddy's Laboratories RDY Stock Holding History

Abacus Wealth Partners’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$254K	Sell	17,549 -62,198	-78%	-$839K	0.03%	267
2026 Q1	$1.1M	Buy	79,747 +740	+0.9%	+$10.3K	0.1%	94
2025 Q4	$1.11M	Buy	+79,007	New	+$1.11M	0.11%	90
2025 Q3	–	Sell	-15,515	Closed	-$233K	–	115
2025 Q2	$233K	Buy	+15,515	New	+$222K	0.04%	94
2025 Q1	–	Sell	-10,120	Closed	-$160K	–	100
2024 Q4	$160K	Buy	+10,120	New	+$152K	0.02%	88

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Abacus Wealth Partners's RDY Position: Q2 2026 in Review

Abacus Wealth Partners reduced its Dr. Reddy's Laboratories (RDY) stake by 78% in Q2 2026, selling an estimated $839K and leaving 17,549 shares worth $254K. The position accounts for 0.03% of the portfolio, ranked #267.

Abacus Wealth Partners first reported a position in RDY in Q4 2024 and has held it in 5 quarters since. The position peaked at $1.11M in Q4 2025. 239 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

Abacus Wealth Partners held 17,549 shares of Dr. Reddy's Laboratories worth $254K as of Q2 2026.
Abacus Wealth Partners sold 62,198 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $839K.
Dr. Reddy's Laboratories made up 0.03% of Abacus Wealth Partners's portfolio in Q2 2026, its #267 holding.
Abacus Wealth Partners first reported a position in Dr. Reddy's Laboratories in Q4 2024 and has held it in 5 quarters since.
Abacus Wealth Partners's Dr. Reddy's Laboratories position peaked at $1.11M in Q4 2025.
239 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Abacus Wealth Partners's 13F filing for Q2 2026, filed 22 Jul 2026.